Publications by authors named "Deborah Maskens"

Claim this Profile
P
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study.
Mohamad E Allaf, Se-Eun Kim, Viraj Master, David F McDermott, Lauren C Harshman, Deborah Maskens

Lancet Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common Sense Oncology: outcomes that matter.
Christopher M Booth, Manju Sengar, Aaron Goodman, Brooke Wilson, Ajay Aggarwal, Deborah Maskens

Lancet Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes: what really matters to patients?
Elshad Hasanov, Jaime O Herrera Caceres, Deborah A Maskens, Rachel H Giles, Andreas M Schmitt

Lancet Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers.
Andrea B Apolo, Pavlos Msaouel, Scot Niglio, Nicholas Simon, Elias Chandran, Deborah Maskens

Am Soc Clin Oncol Educ Book· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-centered care can be improved by joint meetings between cancer patient group leaders and health care providers.
Jaime O Herrera-Caceres, Rand Ajaj, Ricardo Leão, Serena Barello, Francisco Rodriguez-Covarrubias, Deborah Maskens

Patient Educ Couns· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries.
Rachel Giles, Deborah Maskens, Robert Bick, Robin Martinez, Malcolm Packer

Eur Urol Open Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Including the patient voice in the development and implementation of patient-reported outcomes in cancer clinical trials.
Bonnie Addario, Jan Geissler, Marcia K Horn, Linda U Krebs, Deborah Maskens

Health Expect· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?
Hiten D Patel, Maneka Puligandla, Brian M Shuch, Bradley C Leibovich, Anil Kapoor, Deborah Maskens

Future Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient value: Perspectives from the advocacy community.
Bonnie J Addario, Ana Fadich, Jesme Fox, Linda Krebs, Deborah Maskens

Health Expect· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the Management of Rare Kidney Cancers.
Rachel H Giles, Toni K Choueiri, Daniel Y Heng, Laurence Albiges, James J Hsieh, Deborah Maskens

Eur Urol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amsterdam patient charter for global kidney cancer care.
Rachel H Giles, Deborah Maskens,

Eur Urol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney cancer survivorship survey of urologists and survivors: The gap in perceptions of care, but agreement on needs.
Patricia Moretto, Michael A S Jewett, Joan Basiuk, Deborah Maskens, Christina M Canil

Can Urol Assoc J· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis